clinical 4,474 words KG: Lithium for PSP/CBS — Phase 2 Trial 2026-03-28
kind:clinical-trialphase:phase-2intervention:drugtarget:gsk-3bdisease:pspdisease:cbssection:clinical-trialsstate:published
Contents

Lithium for PSP/CBS — Phase 2 Trial

Knowledge Graph

Related Hypotheses (22)

Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.57
Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.80
Vocal Cord Neuroplasticity Stimulation
Score: 0.69
Vagal Afferent Microbial Signal Modulation
Score: 0.63
APOE-Dependent Autophagy Restoration
Score: 0.79

Related Analyses (9)

4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · completed
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived

Related Experiments (12)

4R-Tau Targeting Therapies for PSP and CBS
clinical · proposed · Score: 0.40
Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri
clinical · proposed · Score: 0.40
Brainstem Circuit Modulation for PSP
clinical · proposed · Score: 0.40
CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi
validation · proposed · Score: 0.40
Levodopa Response Determinants in PSP — Biomarker-Guided Pre
clinical · proposed · Score: 0.40

Knowledge Graph (1 edges)

Lithium for PSP/CBS — Phase 2 Trial references BDNF

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)